GAMELIN JOHN (Vice President, R&D) sold 6.7% of their position (12K shares) of CAS MEDICAL SYSTEMS INC on the open market
Open‑market sale worth $19.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/21/2018ACC: 0001449374-18-000010
Officer· Vice President, R&D
Since Aug 2018
-12K
Net shares
Net seller
$19.6K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
12K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1K
Price / share
$1.41
Trade value
$1.41K
% of position
0.6%
5/16/2018
178.08K→177.08K
Common Stock
Direct
Shares
−1K
Price / share
$1.44
Trade value
$1.44K
% of position
0.6%
5/16/2018
177.08K→176.08K
Common Stock
Direct
Shares
−5K
Price / share
$1.66
Trade value
$8.30K
% of position
2.8%
5/17/2018
176.08K→171.08K
Common Stock
Direct
Shares
−5K
Price / share
$1.68
Trade value
$8.40K
% of position
2.9%
5/17/2018
171.08K→166.08K
Total
Net shares
−12K
Net value
-$19.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2018 | S · Sale | −1K | $1.41 | $1.41K | 0.6% | 178.08K | 177.08K |
| Common Stock Direct | 5/16/2018 | S · Sale | −1K | $1.44 | $1.44K | 0.6% | 177.08K | 176.08K |
| Common Stock Direct | 5/17/2018 | S · Sale | −5K | $1.66 | $8.30K | 2.8% | 176.08K | 171.08K |
| Common Stock Direct | 5/17/2018 | S · Sale | −5K | $1.68 | $8.40K | 2.9% | 171.08K | 166.08K |
| Total | −12K | -$19.55K | ||||||
Derivative Transactions0
No derivative transactions reported